32.7 C
New York
Friday, June 12, 2026

Tag: global expansion

Smilegate Launches MMORPG “LORDNINE: Infinite Class” Across Asia

Officially launched on July 31 in Asian regions; supports PC∙mobile cross-platform playSets a new standard for MMORPGs with extensive gameplay freedom, such as...

WeRide Records Another Strong Quarter in Q2 2025: Revenue Hits US$17.8 Million, Robotaxi Revenue Increases 836.7% YoY to US$6.4 Million

BEIJING, July 31, 2025 /PRNewswire/ -- WeRide (Nasdaq: WRD), a global leader in autonomous driving technology, announced its financial results for Q2 2025 on...

WeRide Records Another Strong Quarter in Q2 2025: Revenue Hits US$17.8 Million, Robotaxi Revenue Increases 836.7% YoY to US$6.4 Million

BEIJING, July 31, 2025 /PRNewswire/ -- WeRide (Nasdaq: WRD), a global leader in autonomous driving technology, announced its financial results for Q2 2025 on...

Fosun Tourism Group Signs Syndicated Loan Agreement with Seven International Banks

SHANGHAI, Aug. 1, 2025 /PRNewswire/ -- On July 30, 2025, Fosun Tourism Group ("FTG", or the "Company") signed a €800 million syndicated loan agreement with...

CleaDeep to Unveil New International Brand Arspura at IFA 2025

LOS ANGELES, July 31, 2025 /PRNewswire/ -- CleaDeep, a leading kitchen appliance manufacturer, will officially make its debut at IFA 2025 from September 4 to...

From Trading to Empowerment: HTX Unveils 2025 Mid-Year Performance and Strategic Roadmap

HTX Unveils 2025 Mid-Year Performance and Strategic Roadmap PANAMA CITY, July 31, 2025 /CNW/ -- HTX, a leading global crypto exchange, recently announced its robust...

Immunocore to report second quarter 2025 financial results and host call on August 7, 2025

(OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & GAITHERSBURG, Md., US, July 31, 2025) Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” or the “Company”), a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for patients with cancer, infectious diseases and autoimmune diseases, today announced that it will report second quarter financial results, before the US markets open on Thursday, August 7, 2025.

Equinix Reports Second-Quarter 2025 Results

REDWOOD CITY, Calif., July 30, 2025 /PRNewswire/ -- Deepened customer engagement, with 4,100 deals closed across more than 3,300 customers and $345 million in annualized...

Hydrogen Peroxide Market is expected to generate a revenue of USD 2.92 Billion by 2032, Globally, at 6.50% CAGR: Verified Market Research®

The Hydrogen Peroxide Market presents strong growth opportunities driven by eco-conscious demand from pulp & paper, wastewater treatment, and healthcare sectors. However, safety, storage, and...

Hydrogen Peroxide Market is expected to generate a revenue of USD 2.92 Billion by 2032, Globally, at 6.50% CAGR: Verified Market Research®

The Hydrogen Peroxide Market presents strong growth opportunities driven by eco-conscious demand from pulp & paper, wastewater treatment, and healthcare sectors. However, safety, storage, and...

Through its new collaboration with Thunes, EzyRemit unlocks real-time payments to over 45 countries

EzyRemit Scales Cross-Border Payments with Thunes to Empower Expatriate Communities Globally SINGAPORE, July 30, 2025 /PRNewswire/ -- Thunes, the Smart Superhighway to move money around...

QCI Posts 50% Organic Growth Over Prior Year; Accelerated Global Expansion Across Australia and Asia and Acquisition of VizExplorer Set to Drive Further Gains

SAN DIEGO, July 29, 2025 (GLOBE NEWSWIRE) -- Quick Custom Intelligence (QCI), the global leader in AI and analytics for the casino industry, today announced a 50% organic growth through June 2025 compared to the prior 12 months, underscoring the company’s sustained momentum since its founding in March 2020 by Dr. Ralph Thomas and Andrew Cardno. QCI’s recent acquisition of VizExplorer is expected to unlock additional growth from their acquired customer base.

Hansa Biopharma announces key executive appointments to support continued growth

LUND, Sweden, July 29, 2025 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA) today announced three leadership appointments. Brian Gorman joins Hansa as...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsGlobal expansion